Corona pandemic: Biontech reports on success with vaccine

[ad_1] Mainz-based pharmaceutical company Biontech and its US partner Pfizer can report a breakthrough: a corona vaccine has proven extremely effective in clinical trials. US approval will follow soon. For the first time, there are interim results from the study phase of a corona vaccine, which is relevant for Europe. …

Read More »

Study Data Published: Biontech: Corona Vaccine 90 Percent Effective

[ad_1] Monday, November 9, 2020 Mainz-based pharmaceutical company Biontech presents promising study results. Consequently, the company’s vaccine offers more than 90 percent protection against Covid-19. By the end of the year, 50 million doses of the drug should be available. For the first time, there are interim results from the …

Read More »

Vaccination committee recommendation: risk groups first

[ad_1] Scientific advisers to the federal government rely on the use of corona vaccines. But it is clear that there will not be enough vaccines in the beginning. Therefore, initially preference should be given to risk groups. According to the recommendation of the Permanent Commission on Vaccination (STIKO), the elderly …

Read More »